Butcher; John W.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Butcher; John W..The latest application filed is for "thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors".
- Butcher; John W. - Berlin MA US
- Butcher; John W. - Washington NH
- Butcher; John W. - Telford PA US
- Butcher, John W - Telford PA
| Patent | Date |
|---|---|
| Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors Grant 9,822,107 - Andresen , et al. November 21, 2 | 2017-11-21 |
| Thiazole-substituted Aminoheteroaryls As Spleen Tyrosine Kinase Inhibitors App 20160340351 - Andresen; Brian M. ; et al. | 2016-11-24 |
| Pyrazolyl derivatives as Syk inhibitors Grant 9,242,984 - Machacek , et al. January 26, 2 | 2016-01-26 |
| 2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors Grant 9,216,173 - Altman , et al. December 22, 2 | 2015-12-22 |
| HCV NS3 Protease Inhibitors App 20150266897 - Liverton; Nigel J. ; et al. | 2015-09-24 |
| Azaindoles as Janus kinase inhibitors Grant 9,096,598 - Butcher , et al. August 4, 2 | 2015-08-04 |
| Pyrazolyl Derivatives As Syk Inhibitors App 20150191461 - Machacek; Michelle R. ; et al. | 2015-07-09 |
| Macrocyclic compounds as antiviral agents Grant 8,927,569 - Harper , et al. January 6, 2 | 2015-01-06 |
| Azaindoles As Janus Kinase Inhibitors App 20140303142 - Butcher; John W. ; et al. | 2014-10-09 |
| 2-Pyridyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors App 20140243336 - Altman; Michael D. ; et al. | 2014-08-28 |
| Cycloalkyl-fused Tetrahydroquinolines As Crth2 Receptor Modulators App 20140128367 - Huang; Xianhai ; et al. | 2014-05-08 |
| Cycloalkyl-fused tetrahydroquinolines as CRTH.sub.2 receptor modulators Grant 8,592,383 - Huang , et al. November 26, 2 | 2013-11-26 |
| HCV NS3 protease inhibitors Grant 8,461,107 - Liverton , et al. June 11, 2 | 2013-06-11 |
| Cycloalkyl-fused Tetrahydroquinolines As Crth2 Receptor Modulators App 20120329743 - Huang; Xianhai ; et al. | 2012-12-27 |
| Hcv Ns3 Protease Inhibitors App 20110046161 - Liverton; Nigel J. ; et al. | 2011-02-24 |
| Macrocyclic Compounds As Antiviral Agents App 20100183551 - Harper; Steven ; et al. | 2010-07-22 |
| HCV NS3 Protease Inhibitors App 20100099695 - Liverton; Nigel J. ; et al. | 2010-04-22 |
| N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists Grant 7,259,157 - Liverton , et al. August 21, 2 | 2007-08-21 |
| N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists Grant 7,217,716 - Claiborne , et al. May 15, 2 | 2007-05-15 |
| N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists Grant 7,053,089 - Claiborne , et al. May 30, 2 | 2006-05-30 |
| Radioligand and binding assay Grant 6,838,291 - Butcher , et al. January 4, 2 | 2005-01-04 |
| N-substituted nonaryl-heterocyclic nmda/nr2b antagonists App 20040209889 - Claiborne, Christopher F ; et al. | 2004-10-21 |
| N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists App 20030119811 - Liverton, Nigel J. ; et al. | 2003-06-26 |
| N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists App 20020165241 - Claiborne, Christopher F. ; et al. | 2002-11-07 |
| Radioligand and binding assay App 20020034730 - Butcher, John W. ; et al. | 2002-03-21 |
| Substituted imidazoles having cytokine inhibitory activity Grant 5,859,041 - Liverton , et al. January 12, 1 | 1999-01-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 